MRSA检验的全球市场 2023-2027

MRSA检验的市场规模在2022年～2027年间，预测将成长到6亿8212万美元，在预测期间内预计将以12.13％的年复合成长率增长。

本报告提供MRSA检验市场整体分析，市场规模与预测，趋势，成长促进因素·课题，网罗了约25供应商的供应商分析等资讯。

同时本报告还提供当前全球市场趋势与推动因素以及整体市场环境的最新分析。市场成长的主要因素有葡萄球菌感染疾病的发生率增加，新MRSA诊断试验的引进，医疗保健的自动化和系统整合的引进增加。

目录

第1章 摘要整理

• 市场概要

第2章 市场形势

• 市场生态系统

第3章 市场规模

• 市场定义
• 市场区隔分析
• 市场规模 2022
• 市场预测:2022-2027年的预测

第4章 市场规模实际成果

• 全球MRSA试验市场2017～2021年
• 终端用户市场区隔分析2017-2021
• 类型市场区隔分析2017-2021
• 地区市场区隔分析2017-2021
• 国家市场区隔分析2017-2021

第5章 波特的五力分析

• 五力的摘要
• 买方议价能力
• 供给企业谈判力
• 新加入厂商业者的威胁
• 替代品的威胁
• 竞争的威胁
• 市场情况

第6章 各终端用户市场区隔

• 市场·市场区隔
• 各终端用户比较
• 医院及诊断检验室 - 市场规模与预测 2022-2027
• 学术及调查机关 - 市场规模与预测 2022-2027
• 各终端用户的市场机会

第7章 各类型的市场区隔

• 市场·市场区隔
• 各类型比较
• 分子诊断 - 市场规模与预测 2022-2027
• 免疫诊断 - 市场规模与预测 2022-2027
• 各类型的市场机会

第8章 客户形势

• 客户形势概要

第9章 各地区形势

• 各地区市场区隔
• 各地区比较
• 北美 - 市场规模与预测 2022-2027
• 欧洲 - 市场规模与预测 2022-2027
• 亚洲 - 市场规模与预测 2022-2027
• 其他地区(ROW) - 市场规模与预测 2022-2027
• 美国 - 市场规模与预测 2022-2027
• 德国 - 市场规模与预测 2022-2027
• 英国 - 市场规模与预测 2022-2027
• 日本 - 市场规模与预测 2022-2027
• 加拿大 - 市场规模与预测 2022-2027
• 各地区的市场机会

第10章 促进因素，课题，及趋势

• 推动市场要素
• 市场课题
• 推动因素与课题的影响
• 市场趋势

第11章 业者情势

• 概要
• 业者情势
• 混乱状况
• 产业的风险

第12章 供应商分析

• 交易厂商
• 供应商的市场定位
• 3M Co.
• Abbott Laboratories
• Arlington Scientific Inc.
• Becton Dickinson and Co.
• bioMerieux SA
• Bio Rad Laboratories Inc.
• Bruker Corp.
• Danaher Corp.
• DiaSorin Spa
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• GENSPEED Biotech GmbH
• OpGen Inc.
• Puritan Medical Products Co.
• Uniogen Oy

第13章 附录

Technavio has been monitoring the MRSA testing market and is forecast to grow by $682.12 mn during 2022-2027, accelerating at a CAGR of 12.13% during the forecast period. Our report on the MRSA testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of staphylococcal infections, introduction of new MRSA diagnostic tests, and increased adoption of automation and system integration in healthcare.

Technavio's MRSA testing market is segmented as below:

By End-user

• Hospitals and diagnostic laboratories
• Academic and research institutes

By Type

• Molecular diagnostics
• Immunodiagnostics

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing demand for infection control committees in hospitals as one of the prime reasons driving the MRSA testing market growth during the next few years. Also, rise in use of MRSA quick tests using lab-on-chip technology in hospital settings and the emergence of PCR-free electrochemical POC testing for rapid clinical detection of MRSA will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the MRSA testing market covers the following areas:

• MRSA testing market sizing
• MRSA testing market forecast
• MRSA testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading MRSA testing market vendors that include 3M Co., Abbott Laboratories, ALIFAX Srl, Arlington Scientific Inc., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Bruker Corp., Creative Diagnostics, Danaher Corp., DiaSorin Spa, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GENSPEED Biotech GmbH, OpGen Inc., Puritan Medical Products Co., R Biopharm AG, Sekisui Diagnostics LLC, Uniogen Oy, and ZeptoMetrix LLC. Also, the MRSA testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global MRSA testing market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global MRSA testing market 2017 - 2021 ($ million)
• 4.2 End-user Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• 4.3 Type Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027
• Exhibit 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• 6.4 Academic and research institutes - Market size and forecast 2022-2027
• Exhibit 38: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by End-user
• Exhibit 42: Market opportunity by End-user ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 43: Chart on Type - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Type - Market share 2022-2027 (%)
• 7.2 Comparison by Type
• Exhibit 45: Chart on Comparison by Type
• Exhibit 46: Data Table on Comparison by Type
• 7.3 Molecular diagnostics - Market size and forecast 2022-2027
• Exhibit 47: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
• 7.4 Immunodiagnostics - Market size and forecast 2022-2027
• Exhibit 51: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Type
• Exhibit 55: Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 57: Chart on Market share by geography 2022-2027 (%)
• Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 59: Chart on Geographic comparison
• Exhibit 60: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.10 Japan - Market size and forecast 2022-2027
• Exhibit 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity by geography
• Exhibit 97: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 98: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 100: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 101: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 102: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 103: Matrix on vendor position and classification
• 12.3 3M Co.
• Exhibit 104: 3M Co. - Overview
• Exhibit 105: 3M Co. - Business segments
• Exhibit 106: 3M Co. - Key offerings
• Exhibit 107: 3M Co. - Segment focus
• 12.4 Abbott Laboratories
• Exhibit 108: Abbott Laboratories - Overview
• Exhibit 109: Abbott Laboratories - Business segments
• Exhibit 110: Abbott Laboratories - Key news
• Exhibit 111: Abbott Laboratories - Key offerings
• Exhibit 112: Abbott Laboratories - Segment focus
• 12.5 Arlington Scientific Inc.
• Exhibit 113: Arlington Scientific Inc. - Overview
• Exhibit 114: Arlington Scientific Inc. - Product / Service
• Exhibit 115: Arlington Scientific Inc. - Key offerings
• 12.6 Becton Dickinson and Co.
• Exhibit 116: Becton Dickinson and Co. - Overview
• Exhibit 117: Becton Dickinson and Co. - Business segments
• Exhibit 118: Becton Dickinson and Co. - Key news
• Exhibit 119: Becton Dickinson and Co. - Key offerings
• Exhibit 120: Becton Dickinson and Co. - Segment focus
• 12.7 bioMerieux SA
• Exhibit 121: bioMerieux SA - Overview
• Exhibit 122: bioMerieux SA - Product / Service
• Exhibit 123: bioMerieux SA - Key offerings
• 12.8 Bio Rad Laboratories Inc.
• Exhibit 124: Bio Rad Laboratories Inc. - Overview
• Exhibit 125: Bio Rad Laboratories Inc. - Business segments
• Exhibit 126: Bio Rad Laboratories Inc. - Key news
• Exhibit 127: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 128: Bio Rad Laboratories Inc. - Segment focus
• 12.9 Bruker Corp.
• Exhibit 129: Bruker Corp. - Overview
• Exhibit 130: Bruker Corp. - Business segments
• Exhibit 131: Bruker Corp. - Key news
• Exhibit 132: Bruker Corp. - Key offerings
• Exhibit 133: Bruker Corp. - Segment focus
• 12.10 Danaher Corp.
• Exhibit 134: Danaher Corp. - Overview
• Exhibit 135: Danaher Corp. - Business segments
• Exhibit 136: Danaher Corp. - Key news
• Exhibit 137: Danaher Corp. - Key offerings
• Exhibit 138: Danaher Corp. - Segment focus
• 12.11 DiaSorin Spa
• Exhibit 139: DiaSorin Spa - Overview
• Exhibit 140: DiaSorin Spa - Business segments
• Exhibit 141: DiaSorin Spa - Key offerings
• Exhibit 142: DiaSorin Spa - Segment focus
• 12.12 Eurofins Scientific SE
• Exhibit 143: Eurofins Scientific SE - Overview
• Exhibit 144: Eurofins Scientific SE - Business segments
• Exhibit 145: Eurofins Scientific SE - Key news
• Exhibit 146: Eurofins Scientific SE - Key offerings
• Exhibit 147: Eurofins Scientific SE - Segment focus
• 12.13 F. Hoffmann La Roche Ltd.
• Exhibit 148: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 149: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 150: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 151: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 152: F. Hoffmann La Roche Ltd. - Segment focus
• 12.14 GENSPEED Biotech GmbH
• Exhibit 153: GENSPEED Biotech GmbH - Overview
• Exhibit 154: GENSPEED Biotech GmbH - Product / Service
• Exhibit 155: GENSPEED Biotech GmbH - Key offerings
• 12.15 OpGen Inc.
• Exhibit 156: OpGen Inc. - Overview
• Exhibit 157: OpGen Inc. - Product / Service
• Exhibit 158: OpGen Inc. - Key offerings
• 12.16 Puritan Medical Products Co.
• Exhibit 159: Puritan Medical Products Co. - Overview
• Exhibit 160: Puritan Medical Products Co. - Product / Service
• Exhibit 161: Puritan Medical Products Co. - Key offerings
• 12.17 Uniogen Oy
• Exhibit 162: Uniogen Oy - Overview
• Exhibit 163: Uniogen Oy - Product / Service
• Exhibit 164: Uniogen Oy - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 165: Inclusions checklist
• Exhibit 166: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 167: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 168: Research methodology
• Exhibit 169: Validation techniques employed for market sizing
• Exhibit 170: Information sources
• 13.5 List of abbreviations
• Exhibit 171: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global MRSA testing market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on End-user - Market share 2022-2027 (%)
• Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by End-user ($ million)
• Exhibits43: Chart on Type - Market share 2022-2027 (%)
• Exhibits44: Data Table on Type - Market share 2022-2027 (%)
• Exhibits45: Chart on Comparison by Type
• Exhibits46: Data Table on Comparison by Type
• Exhibits47: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
• Exhibits50: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
• Exhibits51: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibits52: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• Exhibits54: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• Exhibits55: Market opportunity by Type ($ million)
• Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits57: Chart on Market share by geography 2022-2027 (%)
• Exhibits58: Data Table on Market share by geography 2022-2027 (%)
• Exhibits59: Chart on Geographic comparison
• Exhibits60: Data Table on Geographic comparison
• Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits97: Market opportunity by geography ($ million)
• Exhibits98: Impact of drivers and challenges in 2022 and 2027
• Exhibits99: Overview on Criticality of inputs and Factors of differentiation
• Exhibits100: Overview on factors of disruption
• Exhibits101: Impact of key risks on business
• Exhibits102: Vendors covered
• Exhibits103: Matrix on vendor position and classification
• Exhibits104: 3M Co. - Overview
• Exhibits105: 3M Co. - Business segments
• Exhibits106: 3M Co. - Key offerings
• Exhibits107: 3M Co. - Segment focus
• Exhibits108: Abbott Laboratories - Overview
• Exhibits109: Abbott Laboratories - Business segments
• Exhibits110: Abbott Laboratories - Key news
• Exhibits111: Abbott Laboratories - Key offerings
• Exhibits112: Abbott Laboratories - Segment focus
• Exhibits113: Arlington Scientific Inc. - Overview
• Exhibits114: Arlington Scientific Inc. - Product / Service
• Exhibits115: Arlington Scientific Inc. - Key offerings
• Exhibits116: Becton Dickinson and Co. - Overview
• Exhibits117: Becton Dickinson and Co. - Business segments
• Exhibits118: Becton Dickinson and Co. - Key news
• Exhibits119: Becton Dickinson and Co. - Key offerings
• Exhibits120: Becton Dickinson and Co. - Segment focus
• Exhibits121: bioMerieux SA - Overview
• Exhibits122: bioMerieux SA - Product / Service
• Exhibits123: bioMerieux SA - Key offerings
• Exhibits124: Bio Rad Laboratories Inc. - Overview
• Exhibits125: Bio Rad Laboratories Inc. - Business segments
• Exhibits126: Bio Rad Laboratories Inc. - Key news
• Exhibits127: Bio Rad Laboratories Inc. - Key offerings
• Exhibits128: Bio Rad Laboratories Inc. - Segment focus
• Exhibits129: Bruker Corp. - Overview
• Exhibits130: Bruker Corp. - Business segments
• Exhibits131: Bruker Corp. - Key news
• Exhibits132: Bruker Corp. - Key offerings
• Exhibits133: Bruker Corp. - Segment focus
• Exhibits134: Danaher Corp. - Overview
• Exhibits135: Danaher Corp. - Business segments
• Exhibits136: Danaher Corp. - Key news
• Exhibits137: Danaher Corp. - Key offerings
• Exhibits138: Danaher Corp. - Segment focus
• Exhibits139: DiaSorin Spa - Overview
• Exhibits140: DiaSorin Spa - Business segments
• Exhibits141: DiaSorin Spa - Key offerings
• Exhibits142: DiaSorin Spa - Segment focus
• Exhibits143: Eurofins Scientific SE - Overview
• Exhibits144: Eurofins Scientific SE - Business segments
• Exhibits145: Eurofins Scientific SE - Key news
• Exhibits146: Eurofins Scientific SE - Key offerings
• Exhibits147: Eurofins Scientific SE - Segment focus
• Exhibits148: F. Hoffmann La Roche Ltd. - Overview
• Exhibits149: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits150: F. Hoffmann La Roche Ltd. - Key news
• Exhibits151: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits152: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits153: GENSPEED Biotech GmbH - Overview
• Exhibits154: GENSPEED Biotech GmbH - Product / Service
• Exhibits155: GENSPEED Biotech GmbH - Key offerings
• Exhibits156: OpGen Inc. - Overview
• Exhibits157: OpGen Inc. - Product / Service
• Exhibits158: OpGen Inc. - Key offerings
• Exhibits159: Puritan Medical Products Co. - Overview
• Exhibits160: Puritan Medical Products Co. - Product / Service
• Exhibits161: Puritan Medical Products Co. - Key offerings
• Exhibits162: Uniogen Oy - Overview
• Exhibits163: Uniogen Oy - Product / Service
• Exhibits164: Uniogen Oy - Key offerings
• Exhibits165: Inclusions checklist
• Exhibits166: Exclusions checklist
• Exhibits167: Currency conversion rates for US$
• Exhibits168: Research methodology
• Exhibits169: Validation techniques employed for market sizing
• Exhibits170: Information sources
• Exhibits171: List of abbreviations